belimalab 이외의 생물학적 작용제는 SLE 치료제로 허가되지 않았기 때문에, 특정 SLE 환자, 특히 표준 치료에 실패한 환자에게서 시험되었다.
As no biological agent other than belimumab has been licensed as an SLE treatment, tocilizumab has been tested in certain SLE patients, especially those who failed standard therapy.